Dr. Urrutia reviews the methodology and main findings of 2018 review on FABM effectiveness for avoiding pregnancy and disucsses the important limitations of the data including population-based differences in effectiveness, especially among breastfeeding and postpartum individuals. She also introduces and identifies clinical decision-making tools providers and patients regarding choosing an FABM to avoid pregnancy, reviews new technologies currently being applied to FABM use, and discusses the role of the FDA in clearing fertility awareness apps for contraception.

This content is only available to current IIRRM Members.  Please Log in below or click here to become a member.   Time to renew your membership? - Log in below and visit your account page.